Share-Based Compensation	3 Months Ended
Apr. 04, 2026
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation The Company incurred stock-based compensation expense of $3.1 million and $2.5 million in the fiscal three months ended April 4, 2026 and March 29, 2025, respectively. During the fiscal three months ended April 4, 2026, the Company issued new grants of 25,764 restricted stock units (“RSUs”) with a weighted-average grant-date fair value per RSU of $54.02. These new RSU grants are scheduled to vest in one year, in three years, or over three years, depending on the terms of each grant, with vesting dependent on service requirements. Each RSU grant issued during the fiscal three months ended April 4, 2026 will potentially result in the future issuance of one share of the Company’s common stock if the vesting conditions are satisfied. Under the authorization of the 2021 BlueLinx Holdings, Inc. 2021 Long-Term Incentive Plan, 334,842 shares of the Company’s common stock remain authorized and available for future issuances of equity-based compensation awards as of April 4, 2026.

Share-Based Compensation

3 Months Ended

Apr. 04, 2026

Share-Based Payment Arrangement [Abstract]

The Company incurred stock-based compensation expense of $3.1 million and $2.5 million in the fiscal three months ended April 4, 2026 and March 29, 2025, respectively.

During the fiscal three months ended April 4, 2026, the Company issued new grants of 25,764 restricted stock units (“RSUs”) with a weighted-average grant-date fair value per RSU of $54.02. These new RSU grants are scheduled to vest in one year, in three years, or over three years, depending on the terms of each grant, with vesting dependent on service requirements. Each RSU grant issued during the fiscal three months ended April 4, 2026 will potentially result in the future issuance of one share of the Company’s common stock if the vesting conditions are satisfied.

Under the authorization of the 2021 BlueLinx Holdings, Inc. 2021 Long-Term Incentive Plan, 334,842 shares of the Company’s common stock remain authorized and available for future issuances of equity-based compensation awards as of April 4, 2026.